Diabetic Foot Ulcers Market is expected to generate a revenue of USD 2.85 Billion by 2028, Globally, at 10.74% CAGR

Verified Market Research - Seite 2

Key Developments

• On November 2020, B. Braun, one of the world's leading manufacturers of medical devices and pharmaceutical products and services, and Grifols, a leading global producer of plasma-derived medicines and provider of technologies and services for hospitals, clinics and compounding centers announced a global partnership to enhance pharmacy production output and therapy safety.
• On July 2018, Molnlycke acquired German wound care company SastoMed GmbH, with an aim to expand its product offerings to help patients and healthcare professionals to accelerate the wound healing process.
• On December 2019, Orpyx Medical Technologies Inc. launched Orpyx SI Sensory Insoles with remote patient monitoring for the prevention of diabetic foot ulcer.

Key Players

The major players in the market are Acelity L.P. Inc., B. Braun Melsungen AG, BSN Medical GMBH, Coloplast A/S, ConvaTec, Inc., Medline Industries, Inc., Medtronic Plc, Molnlycke Health Care AB, Organogenesis, Inc., and Smith & Nephew Plc.

Verified Market Research has segmented the Global Diabetic Foot Ulcers Market On the basis of Product Type, Ulcer Type, and Geography.

• Diabetic Foot Ulcers Market, By Product Type
• Advanced Wound Dressings
• Skin Substitutes
• Growth Factors
• Negative Pressure Wound Therapy Devices
• Other Devices
• Diabetic Foot Ulcers Market, By Ulcer Type
• Neuropathic Ulcers
• Ischemic Ulcers
• Neuro-Ischemic Ulcers
• Diabetic Foot Ulcers Market, by Geography
• North America
• U.S
• Canada
• Mexico
• Europe
• Germany
• France
• U.K
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• ROW
• Middle East & Africa
• Latin America

Browse Related Reports: